Bone Biologics Corp - Common Stock (NQ:BBLG)

0.4731 -0.0019 (-0.40%)

Delayed Quote Updated: 11:57 AM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bone Biologics Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

These stocks are moving in today's pre-market session ↗

September 17, 2026

Via Chartmill

Bone Biologics Expands Trial Sites

September 08, 2026

Addition of three sites strengthens expectation to complete enrollment by year-end 2026

From BONE BIOLOGICS CORPORATION

Via GlobeNewswire

Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 03, 2026

From BONE BIOLOGICS CORPORATION

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 12, 2026

Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million. Definium Therapeutics

Via Benzinga

Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1

August 12, 2026

Milestone strengthens manufacturing flexibility and supports pivotal study readiness

From BONE BIOLOGICS CORPORATION

Via GlobeNewswire

Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

July 23, 2026

Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2 2027

From BONE BIOLOGICS CORPORATION

Via GlobeNewswire

Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

July 07, 2026

$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash

From BONE BIOLOGICS CORPORATION

Via GlobeNewswire

Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗

June 08, 2026

href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell...

Via Benzinga

Topics Stocks

Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1

May 19, 2026

Milestone advances commercial and manufacturing readiness ahead of anticipated pivotal study scale-up

From BONE BIOLOGICS CORPORATION

Via GlobeNewswire

Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

January 08, 2026

Key accomplishments include expanded rhNELL-1 shelf life, advanced NB1 development, strengthened balance sheet, and maintained Nasdaq compliance

From BONE BIOLOGICS CORPORATION

Via GlobeNewswire

Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

December 23, 2025

Milestone advances manufacturing readiness and supports long-term commercialization strategy

From BONE BIOLOGICS CORPORATION

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 05, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

September 04, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Discover the most active stocks in Thursday's session. ↗

September 04, 2025

Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 04, 2025

Via Benzinga

Top stock movements in today's session. ↗

September 04, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

Which stocks are gapping on Thursday? ↗

September 04, 2025

Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Top movers in Thursday's pre-market session ↗

September 04, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 04, 2025

Via Benzinga

Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook

September 04, 2025

From Bone Biologics Corporation

Via Business Wire

Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference

September 03, 2025

From Bone Biologics Corporation

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 19, 2025

Via Benzinga

Bone Biologics Announces Closing of $5.0 Million Public Offering

June 30, 2025

From Bone Biologics Corporation

Via Business Wire

Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket ↗

June 30, 2025

Via Benzinga

Get insights into the top gainers and losers of Friday's after-hours session. ↗

June 27, 2025

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Valuation, Nasdaq Compliance Etc. – More Stocks Inside

June 27, 2025

Via AB Newswire

Topics Regulatory Compliance

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

June 27, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Why Is Bone Biologics Stock Surging On Friday? ↗

June 27, 2025

Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.

Via Benzinga

Topics Intellectual Property

Bone Biologics Announces Pricing of $5.0 Million Public Offering

June 27, 2025

From Bone Biologics Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.